2026 S&P 500 Outlook: Look For Pharma Sector To Lead The Way With Potential Changes
2025-12-29 09:20:00 ET
I am expecting 2026 to be a big year for the S&P 500 Index ( SPY , SPX , SP500 ), and it is quite simply because the pharmaceutical sector is going to lead the way. Thus, I'm incorporating a Strong Buy rating. One big reason would be because of the powerhouse in the industry that just keeps on gaining traction, which is Eli Lilly ( LLY ) with its FDA-approved obesity drug ZEPBOUND [tirzepatide], along with other big names in this sector as well, like Novartis ( NVS ) and Merck ( MRK ). Speaking of Merck, this continues to deliver with its key oncology drug KEYTRUDA for the treatment of patients with several types of solid tumors....
Read the full article on Seeking Alpha
For further details see:
2026 S&P 500 Outlook: Look For Pharma Sector To Lead The Way With Potential Changes
NASDAQ: NVS
NVS Trading
0.14% G/L:
$143.57 Last:
367,989 Volume:
$142.47 Open:
